New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Recipes & Nutrition

Recipe: Slow-cooked Mediterranean chicken tagine

This slow-cooked fragrant tagine benefits from antibacterial properties

READ MORE
Avocado pear

Recipes & Nutrition

Naturally good food: the diets proven to boost the body against Parkinson’s

Diets from around the world that help Parkinson’s symptoms

READ MORE
Rob Deering participating in the Yorkshire marathon

Interviews

Comedian Rob Deering on raising nearly £100,000 for Parkinson’s UK

"I’ve run nine marathons to raise money for Parkinson’s"

READ MORE